| Sr. No. |
Name of Principal Investigator |
Title of Project |
Sanctioned Year Period |
Status |
Amount Sanctioned |
| 1. |
Dr. A. R. Madgulkar |
Skin targeting using lipid Nanoparticles: Formulation and Evaluation |
2008-10 |
Completed
|
2,00,000/- |
| 2. |
Dr. M. C. Damle |
Simultaneous Determination of Drugs In Combination Dosage Forms by Stability-Indicating Method. |
2008-10 |
Completed
|
1,50,000/- |
| 3. |
Dr S. V. Bhandari |
Design, synthesis and biological evaluation of novel antineoplastic agents using molecular modeling studies |
2008-10 |
Completed
|
1,50,000/- |
| 4. |
Mrs. M.R.P. Rao |
Characterization and Evaluation of Natural Polysaccharide as Novel Pharmaceutical Excipient |
2008-10 |
Completed
|
2,00,000/- |
| 5. |
Dr N. S. Vyawahare |
Preparation and preclinical evaluation of herbal formulation for obesity |
2008-10 |
Completed
|
2,00,000/- |
| 6. |
Dr. S. J. Kshirsagar |
Design, Development of Oral Dosage Forms for Colon- Specific Drug Delivery Using Enteric Polymers |
2008-10 |
Completed
|
1,50,000/- |
| 7. |
Dr. T. S. Chitre |
Design, Synthesis And Biological Evaluation Of Some Non-Nucleoside HIV-1 RT Inhibitors Using Structure Optimization Through Molecular Modeling Studies |
2009-11 |
Completed |
3,00,000/- |
| 8. |
Mr. V. S. Joshi |
Pharmacognostic and Pharmacological Evaluation of Immunomodulatory Activity of Some Traditional Medicinal Plants |
2009-11 |
Completed |
2,00,000/- |
| 9. |
Dr. S. V. Gandhi |
Bioanalytical HPLC Method Development and validation for the estimation of lornoxicam |
2009-11 |
Completed |
3,00,000/- |
| 10. |
Dr. M. R. Bhalekar |
Study of novel methods to improve the bioavailability of a drug by transdermal drug delivery system. |
2009-11 |
Completed |
2,00,000/ |
| 11. |
Mrs. M. V. Dhoka |
Profile of the drugs used in combination for the treatment of Chronic bronchitis |
2009-11 |
Completed |
2,00,000/ |
| 12. |
Mrs. R. N. Mirajkar |
Topical herbal Emulgel |
2010-12 |
Completed |
2,00,000/ |
| 13. |
Dr. M. M. Bandivadekar |
Formulation and evaluation of solid self-emulsifying drug delivery system to improve the dissolution profile of poorly soluble drug |
2010-12 |
Completed |
2,00,000/ |
| 14. |
Mr. P. B Deshpande |
Validated stability indicating method development for determination of drugs in pharmaceutical formulations. |
2010-12 |
Completed |
1,50,000/- |
| 15. |
Dr. A. R. Madgulkar |
Formulation development and in-vivo evaluation of trans mucosal bioadhesive drug delivery system. |
2012-14 |
Completed |
3,00,000/- |
| 16. |
Dr. S. V. Bhandari |
Development of selective anticancer agents by pharmacophore optimization using molecular modeling studies and synthesis, characterization, and in vitro screening using cell line assays and toxicity studies. |
2012-14 |
Completed |
2,95000/- |
| 17. |
Mr. R. R. Padalkar |
Formulation development and in-vivo evaluation of nasal drug delivery system. |
2012-14 |
Completed |
3,00,000/- |
| 18. |
Mrs. A. A. Avalaskar |
Formulation and evaluation of polyherbal tablets having Sesbania grandiflora as a major component for its anti inflammatory activity |
2012-14 |
Completed |
2,20,000/- |
| 19. |
Mrs. S. N. Narkhede |
Preclinical evaluation of polyherbal formulation for female sexual dysfunction |
2012-14 |
Completed |
2,00,000/- |
| 20. |
Dr. Mangesh R Bhalekar |
Development of chloroquine nanoparticles for oral treatment of Rheumatoid arthritis |
2013-15 |
Completed |
2,50,000/- |
| 21. |
Dr. Mrinalini C. Damle |
Development and validation of stability indicating method for Active Pharmaceutical Ingredients. |
2013-15 |
Completed |
1,50,000/ |
| 22. |
Dr. Sanjay J. Kshirsagar |
Design and development of Liposomes for colon targeted drug delivery |
2013-15 |
Completed |
2,30,000/ |
| 23. |
Dr. Trupti S Chitre |
Development of Metallocenes: A modified Approach towards Resistant Tuberculosis |
2013-15 |
Completed |
2,80,000/ |
| 24. |
Dr. Ashwini R. Madgulkar |
Permeation Enhancement of Poorly Bioavailable Drug Using Nanoparticulates Of Thiolated Xyloglucans |
2014-16 |
Completed |
2,30,000/- |
| 25. |
Dr. Monica R. P. Rao |
Characterization and evaluation of modified polysaccharide as a novel pharmaceutical excipient |
2014-16 |
Completed |
2,20,000/- |
| 26. |
Dr. Shashikant V. Bhandari |
Development of Potential Antitubercular agents using Pharmacophore optimization by Molecular Modelling Studies |
2014-16 |
Completed |
2,20,000/- |
| 27. |
Dr. Santosh V. Gandhi |
Bioanalytical Method Development and Validation for Determination of Pharmaceuticals in Biological Samples |
2014-16 |
Completed |
1,40,000/- |
| 28. |
Mr. Padmanabh B. Deshpande |
Stability indicating method development and validation for simultaneous estimation of drugs as bulk and in pharmaceutical formulations |
2014-16 |
Completed |
1,00,000/- |
| 29. |
Mrs. Shital M. Patil |
Development of some Anti-HIV agents |
2014-16 |
Completed |
1,60,000/- |
| 30. |
Dr. M. C. Damle |
Development and validation of stability indicating method for marker compound in selected herbs |
2016-18 |
Completed |
1,00,000/- |
| 31. |
Dr. Trupti Chitre |
Metallocenes and their B-cyclodextrin conjugates: A step towards Resistant tuberculosis |
2016-18 |
Completed |
1,90,000/- |
| 32. |
Mrs. Kalyani Asgaonkar |
Development of some Anti- tubercular agents |
2016-18 |
Completed |
1,70,000/- |
| 33. |
Mrs. Amruta Avalaskar |
Formulation and standardization of Adhulsa lozenges for pediatric patients in the management of asthma |
2016-18 |
Completed |
2,00,000/- |
| 34. |
Mrs. Swati Narkhede |
A study of nootropic activity of polyherbal formulation in laboratory animals |
2016-18 |
Completed |
1,70,000/- |
| 35. |
Mrs. Reshma Mirajkar |
Formulation development of an in situ gel forming system for controlled delivery |
2016-18 |
Completed |
1,70,000/- |
|
TOTAL (Rs.) |
70,95,000/- |
